Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1992 1
1993 2
1994 5
1995 1
1996 1
1997 7
1998 4
1999 10
2000 6
2001 5
2002 1
2004 1
2005 5
2006 3
2007 3
2008 1
2009 5
2010 7
2011 3
2012 4
2013 3
2014 3
2015 4
2016 4
2017 4
2018 4
2019 3
2020 3
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 24141796

99 results

Results by year

Filters applied: . Clear all
Page 1
Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.
Pichichero ME, Latiolais T, Bernstein DI, Hosbach P, Christian E, Vidor E, Meschievitz C, Daum RS. Pichichero ME, et al. Pediatr Infect Dis J. 1997 Sep;16(9):863-70. doi: 10.1097/00006454-199709000-00009. Pediatr Infect Dis J. 1997. PMID: 9306481 Clinical Trial.
One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
Lin TY, Wang YH, Huang YC, Chiu CH, Lin PY, Chen CJ, Chavand P, Ortiz E. Lin TY, et al. Int J Infect Dis. 2007 Nov;11(6):488-95. doi: 10.1016/j.ijid.2007.01.006. Epub 2007 Mar 8. Int J Infect Dis. 2007. PMID: 17349809 Free article. Clinical Trial.
Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants.
Tregnaghi M, Zambrano B, Santos-Lima E. Tregnaghi M, et al. Pediatr Infect Dis J. 2012 Jan;31(1):e24-30. doi: 10.1097/INF.0b013e318242460a. Pediatr Infect Dis J. 2012. PMID: 22157567
Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
Lagos R, Kotloff K, Hoffenbach A, San Martin O, Abrego P, Ureta AM, Pines E, Blondeau C, Bailleux F, Levine MM. Lagos R, et al. Pediatr Infect Dis J. 1998 Apr;17(4):294-304. doi: 10.1097/00006454-199804000-00006. Pediatr Infect Dis J. 1998. PMID: 9576383 Clinical Trial.
99 results